Navigation Links
Parkinson's Drugs Linked to Behavior Problems in Study
Date:3/29/2011

TUESDAY, March 29 (HealthDay News) -- Parkinson's disease drugs called dopamine agonists appear to cause impulse control problems in almost one-quarter of patients, says a new study.

Previous research has linked dopamine agonists, which include Mirapex (pramipexole) and Requip (ropinirole), to impulse control disorders, such as gambling addiction and hypersexuality, and to compulsive behaviors, such as binge eating, overspending and excessive computer use.

In this study, Mayo Clinic researchers analyzed Parkinson's disease patient records over two years.

"What we found was that as many as 22 percent of patients during that two-year period had a new-onset impulse control disorder," lead investigator and neurology fellow Dr. Anhar Hassan said in a Mayo Clinic news release.

The higher the dose of dopamine agonist, the more likely a patient was to develop an impulse control disorder, the researchers found.

"One in four patients who were on a medium therapeutic dose of the medication had an impulse control disorder. For patients who were taking a higher range of the medication, about one in three developed an impulse control disorder," Hassan said.

The study was recently published online in the journal Parkinsonism and Related Disorders.

Patients taking dopamine agonists and their families need to watch for any behavior changes, Hassan said. Reducing the dose or going off the medication usually resolves behavior problems within a few days to a month.

More information

We Move has more about drugs used to treat Parkinson's disease.

-- Robert Preidt

SOURCE: Mayo Clinic, news release, March 23, 2011


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Discovery in liver cancer cells provides new target for drugs
2. Study Questions Rise in Use of Certain Cholesterol Drugs
3. Elderly victims of abuse often use alcohol or drugs, study says
4. Know your drugs: A primer for chemical and life science professionals is ACS Webinars topic
5. Researchers develop synthetic compound that may lead to drugs to fight pancreatic, lung cancer
6. MU chemist discovers shortcut for processing drugs
7. Popular drugs for common male health problems can affect their sexual health
8. Where are new schizophrenia drugs? Experts convene to explore genetic and epigenetic solutions
9. Doctors lax in monitoring potentially addicting drugs
10. Non-steroidal anti-inflammatory drugs linked to increased risk of erectile dysfunction
11. Seniors Concerned About Side Effects of Heart Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Parkinson's Drugs Linked to Behavior Problems in Study
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... Room (ER) on Wednesday, August 16, to community partners. The newly renovated ER ... “Fast Track” area for minor emergencies, eight semi-private rooms to deliver patient results, ...
(Date:8/17/2017)... ... 17, 2017 , ... An August 2 article on NextShark discusses ... largely influenced by the growing popularity of “pretty boys” in both K-Pop and television ... of male appearance are changing not only in the Asian nation, where plastic surgery ...
(Date:8/17/2017)... (PRWEB) , ... August 17, 2017 , ... ... care professionals, today announced that it has raised $1.675 M in seed funding ... Rethink Education, Lumina Foundation, and Techstars Venture Capital Fund are the company’s primary ...
(Date:8/17/2017)... ... August 17, 2017 , ... Momkus McCluskey Roberts LLC ... Parks is a member of the firm’s Commercial Litigation and Employment Law groups. , ... wealth of knowledge in matters of employment litigation, commercial litigation and business disputes. Her ...
(Date:8/17/2017)... ... 2017 , ... Finalists in the 2017 (second annual) ... awards recognize the world’s best employers and the human resources professionals, teams, achievements ... to work. , A diverse group of organizations and individuals around the world ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a clinical-stage ... its financial results for the second quarter ended June ... second quarter 2017 and to date: ... programs for the Company,s lead project, BL-8040: ... with BL-8040 as novel stem cell mobilization treatment for ...
(Date:8/7/2017)... Insightin Health, provider of data-driven decision-making ... announced the selection of Michael Wood ... as of February 2017. In this role, Wood will ... our clients. Wood brings with him more than ... analytics within the healthcare industry. Wood formerly served ...
(Date:8/7/2017)... -- Diplomat Pharmacy, Inc. (NYSE: DPLO ) today ... effective Aug. 7, 2017. ... interests and will serve as president emeritus during a planned, ... in multiple leadership roles since he joined Diplomat with the ... provided decisive, strategic leadership which continues to benefit our patients ...
Breaking Medicine Technology: